
Blbk Pharmaceuticals Private Limited
Manufactures ayurvedic products since 2001, based in Delhi.
Manufactures ayurvedic products since 2001, based in Delhi.
Blbk Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 February 2001 and has a history of 24 years and one month. Its registered office is in North West Delhi, Delhi, India.
The Corporate was formerly known as Nitika Ayurvedics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.92 M.
The company currently has active open charges totaling ₹6.57 M. The company has closed loans amounting to ₹1.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shelandra Kumar and Atul Singh serve as directors at the Company.
North West Delhi, Delhi, India
+91-XXXXXXXXXX
U74899DL2001PTC109844
109844
Private Limited Indian Non-Government Company
28 Feb 2001
30 Sep 2023
31 Mar 2023
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shelandra Kumar ![]() | Director | 30-Dec-2017 | Current |
Atul Singh ![]() | Director | 24-Feb-2020 | Current |
Blbk Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.48% decrease. The company also saw a substantial improvement in profitability, with a 42.03% increase in profit. The company's net worth Soared by an impressive increase of 61699.33%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Blbk Pharmaceuticals had a public holding of 77.60%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹6.57 M
₹19.64 M
Date | Lender | Amount | Status |
---|---|---|---|
24 Mar 2022 | Uco Bank | ₹0.57 M | Open |
26 Jun 2020 | Uco Bank | ₹6.00 M | Open |
25 May 2006 | State Bank Of India | ₹0.72 M | Satisfied |
25 May 2006 | State Bank Of India | ₹0.72 M | Satisfied |
06 Apr 2005 | State Bank Of India | ₹1.20 M | Satisfied |
Unlock and access historical data on people associated with Blbk Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Blbk Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blbk Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Uco Bank of Rs. 6.00 M registered on 26 Jun 2020 with Charge ID 100354991 was modified on 30 Sep 2023.
Blbk Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Blbk Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
A charge with Uco Bank amounted to Rs. 0.57 M with Charge ID 100586275 was registered on 24 Mar 2022.
A charge with Uco Bank amounted to Rs. 6.00 M with Charge ID 100354991 was registered on 26 Jun 2020.
A charge registered on 25 May 2006 via Charge ID 10007786 with State Bank Of India was fully satisfied on 25 Jun 2020.
Blbk Pharmaceuticals Private Limited was incorporated on 28 Feb 2001.
The authorized share capital of Blbk Pharmaceuticals Private Limited is ₹ 2.50 M and paid-up capital is ₹ 1.92 M.
Currently 2 directors are associated with Blbk Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Blbk Pharmaceuticals Private Limited is Ad-4C Pitampura India, Delhi, 110034.
The corporate identification number (CIN) of Blbk Pharmaceuticals Private Limited is U74899DL2001PTC109844 and the company number is 109844 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Blbk Pharmaceuticals Private Limited has fallen by -3.48%.
The financial reports for the fiscal year 2023 indicates that The net worth of Blbk Pharmaceuticals Private Limited has experienced an upsurge of 61699.33%.
As per the financial statements for fiscal Year 2023, The total open charges for Blbk Pharmaceuticals Private Limited amount to ₹ 6.57 M.
The most recent Balance Sheet for Blbk Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
NS
RS
UR